Source: press CNBC•
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. A drug from Amgen could give patients with a notoriously aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca, a study found.
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.
A drug from Amgen could give patients with a notoriously aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca, a study found.
